01—Abstract
Summary
Summary of the 6-K filed January 23, 2026. Cited figures are marked; the original filing is the authoritative source.
James Hardie Industries plc (ASX/NYSE ticker JHX) filed this Form 6-K on January 23, 2026, furnishing two ASX Appendix 3G notifications.
Each reports the issue of unquoted ordinary shares, dated January 19, 2026, that relate to a previously announced Appendix 3B. The filing does not describe any new financing or change in business strategy. The first notification covers 4,074 ordinary shares issued on January 12, 2026, at USD 0.68850000 per share.
The second covers 17,955 ordinary shares issued on January 13, 2026, at USD 0.68810000 per share. The filing states that the shares were issued for cash consideration in US dollars. It also says the shares are issued in respect of the settlement of certain AZEK equity awards that were outstanding when the merger closed on July 1, 2025, under the merger agreement dated March 23, 2025, as amended, among James Hardie, Juno Merger Sub Inc. and The AZEK Company Inc. After the January 13 issuance, the filing reports 430,436,032 quoted CHESS Depositary Interests (1:1) on ASX.
It also reports 149,616,246 unquoted ordinary shares, 5,415,537 unquoted restricted stock units and 269,221 unquoted options expiring November 3, 2027, with an exercise price of USD 33.05. The ASX waiver from Listing Rule 2.4 for these issuances was requested on July 7, 2025 and granted on July 16, 2025.
02—Key points
Key Highlights
- Two Appendix 3G notices report issuance of unquoted JHX ordinary shares: 4,074 shares on January 12, 2026 and 17,955 shares on January 13, 2026.
- Issue prices were USD 0.68850000 per share (first tranche) and USD 0.68810000 per share (second tranche), both stated as cash consideration in US dollars.
- The shares settle certain AZEK equity awards that were outstanding at the July 1, 2025 closing of the merger with The AZEK Company Inc.
- After the January 13, 2026 issuance, quoted CHESS Depositary Interests total 430,436,032 on ASX.
- Unquoted ordinary shares on issue after the January 13, 2026 issuance total 149,616,246, up from 149,602,365 after the January 12 issuance.
- Unquoted restricted stock units total 5,415,537 and unquoted options expiring November 3, 2027 (exercise price USD 33.05) total 269,221.
- ASX granted a waiver from Listing Rule 2.4 on July 16, 2025 for these unquoted securities issuances, following a request made on July 7, 2025.
03—Questions
Frequently Asked Questions
Does this filing indicate new capital raising by James Hardie?
No. The filing describes issuances of ordinary shares to settle AZEK equity awards outstanding at the merger closing on July 1, 2025. It does not describe a new placement or offering of securities.
Why were these shares issued?
The filing states that the shares were issued in respect of the settlement of certain AZEK equity awards outstanding as of the closing of the merger between James Hardie and The AZEK Company Inc., which was consummated on July 1, 2025.
What prices were the shares issued at?
The filing reports an issue price of USD 0.68850000 per share for the 4,074 shares issued on January 12, 2026, and USD 0.68810000 per share for the 17,955 shares issued on January 13, 2026.
How many JHX securities are on issue after these issuances?
The filing reports 430,436,032 quoted CHESS Depositary Interests (1:1) on ASX. It also reports 149,616,246 unquoted ordinary shares, 5,415,537 unquoted restricted stock units and 269,221 unquoted options expiring November 3, 2027 with an exercise price of USD 33.05.
Why are these securities unquoted, and was regulatory relief needed?
The securities are not quoted or intended to be quoted on ASX. James Hardie applied for a waiver from ASX Listing Rule 2.4 on July 7, 2025 in respect of these issuances, and ASX granted the waiver on July 16, 2025.
04—Continue